Loading clinical trials...
Loading clinical trials...
Use of Artificial Intelligence in Breast Cancer Screening: Impact of AI-Assisted Single Reading by One Radiologist on Screening Quality Indicators Compared to Standard Double Reading by Two Radiologists Without AI
Conditions
Interventions
Group with AI iCAD version 3
Group without AI
Locations
1
Czechia
University Hospital Olomouc
Olomouc, Czechia
Start Date
October 6, 2025
Primary Completion Date
October 5, 2028
Completion Date
October 5, 2028
Last Updated
April 2, 2026
NCT07236840
NCT07079592
NCT07265427
NCT06957093
NCT06934239
NCT02620852
Lead Sponsor
University Hospital Olomouc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions